BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3742882)

  • 1. Omeprazole: effects on oxidative drug metabolism in the rat.
    Henry DA; Gerkens JF; Brent PJ; Dosen PJ
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):377-81. PubMed ID: 3742882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole: effects on oxidative drug metabolism.
    Henry DA; Somerville KW; Kitchingman G; Langman MJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):195-200. PubMed ID: 6487457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cimetidine on drug metabolism in rat pups.
    Ikediobi CO; Kwanashie HO; Osuide G; Wambebe C
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):1-7. PubMed ID: 1936056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine and omeprazole on aspirin- and taurocholate-induced gastric mucosal damage in the rat.
    Utley RJ; Salim AS; Carter DC
    Gut; 1985 Aug; 26(8):770-5. PubMed ID: 4018641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
    Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
    Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of omeprazole in animals and man--an overview.
    Regårdh CG; Gabrielsson M; Hoffman KJ; Löfberg I; Skånberg I
    Scand J Gastroenterol Suppl; 1985; 108():79-94. PubMed ID: 3858978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion.
    Wallmark B; Jaresten BM; Larsson H; Ryberg B; Brändström A; Fellenius E
    Am J Physiol; 1983 Jul; 245(1):G64-71. PubMed ID: 6307064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
    Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
    Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
    De Graef J; Woussen-Colle MC
    Gastroenterology; 1986 Aug; 91(2):333-7. PubMed ID: 2873074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.
    Hetzel DJ; Shearman DJ
    Br J Clin Pharmacol; 1984 Oct; 18(4):587-90. PubMed ID: 6487498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cimetidine, ranitidine and omeprazole on hepatic flow of the artificially perfused rat liver.
    Sehayek E; Missri A; Jedwab M; Bar-Meir S
    Isr J Med Sci; 1985 Sep; 21(9):765-6. PubMed ID: 4055340
    [No Abstract]   [Full Text] [Related]  

  • 15. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
    Im WB; Blakeman DP; Davis JP
    Biochem Biophys Res Commun; 1985 Jan; 126(1):78-82. PubMed ID: 2982382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omeprazole and polyethylene glycol-400 on antipyrine elimination by the isolated perfused rat liver.
    Webster LK; Jones DB; Mihaly GW; Smallwood RA
    J Pharm Pharmacol; 1984 Jul; 36(7):470-2. PubMed ID: 6146695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
    Humphries TJ
    Dig Dis Sci; 1991 Dec; 36(12):1665-9. PubMed ID: 1748033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aging on hepatic elimination of cimetidine and subsequent interaction of aging and cimetidine on aminopyrine metabolism.
    Henderson GI; Speeg KV; Roberts RK; Perez A; Schenker S
    Biochem Pharmacol; 1988 Jul; 37(13):2667-73. PubMed ID: 3390226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibition--the ultimate control of acid secretion?
    Zdon MJ; Ballantyne GH; Schafer DE; Tyshkov M; Cambria RP; Modlin IM
    J Surg Res; 1986 Apr; 40(4):353-61. PubMed ID: 2422442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NC-1300-O-3 on gastric mucus secretion and prostaglandin release in rats.
    Matsukura H; Masuda M; Uchida A; Kamishiro T
    Jpn J Pharmacol; 1994 Aug; 65(4):319-26. PubMed ID: 7990269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.